Search

During late Palaeozoic time, extensive magmatism and associated ore deposits were developed in the eastern Tianshan orogenic belt (ETOB), Northwest China, which is part of the Central Asian Orogenic Belt. To understand the petrogenesis of the intrusions in this area, we performedin situzircon U–Pb and Hf isotopic analyses on the Tuwu–Yandong (TW–YD) stocks and the Xianshan, Hulu, Luodong, and Poshi batholiths. Two major suites of intrusive rocks have been recognized in the ETOB: (1) 338–339 Ma plagiogranite porphyries and 265–300 Ma ultramafic and mafic rocks, of which the former are associated with 323 Ma porphyry Cu–Mo deposits and have enriched radiogenic Hf isotopic compositions (ϵHf(t) = +11.5 to +15.6), which were derived from a depleted mantle source, whereas the latter are associated with 265–300 Ma magmatic Ni–Cu deposits and have variable Hf isotopic compositions (ϵHf(t) = −10.3 to +14.3), indicating an origin via the hybridization of depleted mantle magma and variable amounts of ancient lower-crustal components. The proposed magma sources, combined with the geochemical differences between these two suites of intrusive rocks, indicate that in the lower to middle Carboniferous, a N-dipping subduction zone beneath the Dananhu arc triggered the emplacement of granitic porphyries in the Tousuquan and Dananhu island arc belt in the east Tianshan, leading to the formation of the TW and YD porphyry Cu–Mo deposits. In the Upper Carboniferous to Lower Permian, large mafic–ultramafic complexes were emplaced during the closure of the ancient Tianshan Ocean, resulting in the formation of several magmatic Cu–Ni sulphide deposits. [ABSTRACT FROM AUTHOR]

Methicillin-resistant Staphylococcus aureus (MRSA) have become increasingly prevalent as nosocomial pathogens, especially in burn patients, which is the leading cause of their death. A drug delivery system of chitosan-collagen hydrogel incorporated with lysostaphin (CCHL) based on the lysostaphin gauze was developed for MRSA infected burn wounds. CCHL scaffold consisted of numerous interconnected sphericles and tubular bodies with an average diameter of 100--200 µµm, 20--60-fold swelling, high water retention capacity, and cell proliferation properties. The minimal inhibitory concentration of CCHL was 0.053 U/mL. By the second week after its application on MRSA infected third-degree burn wounds, no bacteria could be detected and the burn wounds had started healing. Therefore, CCHL should be studied further as a promising candidate of burn treatment dressing against MRSA infections for clinics. [ABSTRACT FROM AUTHOR]

Abstract: In this work, 5-fluorouracil-loaded- poly(l-lactic)-polyethylene glycol/polyethylene glycol (5-FU-loaded-PLLA–PEG/PEG) nanoparticles were prepared using a novel reverse emulsion-solution enhanced dispersion by supercritical fluids (reverse emulsion-SEDS) technique in an effort to obtain an efficient drug delivery system. In the experiment, 5-FU and PEG were dissolved in water PLLA–PEG was dissolved in organic solution, the aqueous solution was added dropwise to the organic solution under magnetic stirring, a reverse emulsion was immediately formed. The reverse emulsion was dried by a SEDS process so that 5-FU-loaded-PLLA–PEG/PEG nanoparticles (5-FU-NPs) were obtained. The particle size, size distribution, surface morphology, and physical and chemical properties of the 5-FU-NPs were investigated by laser diffraction particle size analysis, scanning electron microscopy (SEM), Fourier transform infrared spectrometry (FTIR) and thermogravimetric analysis (TGA). The drug encapsulation efficiency (EE), drug loading (DL), in vitro release profile and pharmacokinetics of 5-FU-NPs in rat plasma were investigated by high-performance liquid chromatography (HPLC). The in vivo tumor inhibition effect, increase in lifespan and hepatotoxicity of placebo-NPs, 5-FU and 5-FU-NPs were determined using H22 tumor-bearing ICR mice. These results collectively suggest that 5-FU-NPs prepared using SEDS have potential anti-tumor applications as a controlled drug release dosage form without harmful drug toxicity. [Copyright &y& Elsevier]

Lysostaphin, a specific endopeptidase enzyme derived from Staphylococcus aureus, is a bactericidal agent against Staphylococcus and difficult to be drug-resistant. This study established the monoclonal antibody affinity chromatography to obtain lysostaphin of high purity for drug-use standard. The purified Lysostaphin was of > 95% purity and its recovery rate more than 90%. Moreover, the affinity column kept its efficiency of purification invariable after more than 30 times repeat. Also, the dye release assay validated that the purified lysostaphin had significant bactericidal activity. This method was simple and of high efficacy for the lysostaphin purification and showed its potency in commercial production.